Biologic Modifiers and Chemoprevention of Cancer of the Oral Cavity

Author:
  • WRWilliam J. Richtsmeier
    William J. Richtsmeier

Abstract
An oncologist beginning the study of squamous-cell carcinoma of the upper aerodigestive tract is often overwhelmed by the differences in presentation, staging, biologic behavior, and treatment depending on the precise site in the head and neck. In considering the importance of the report by Lippman et al. in this issue of the Journal,1 readers who are not oncologists need to place the cancers studied in perspective. Are squamous-cell carcinomas of the head and neck different from other squamous-cell carcinomas, and is a tumor in the oral cavity different from one elsewhere in the head and neck? It is true that . . .